# Mitsubishi Corporation (Americas)

> Mitsubishi Corporation (Americas) is a VC fund backing Life Science. See 2 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: New York, United States
- Total investments: 2
- Last investment: Dec 2024
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/mitsubishi-corporation
- Website: https://www.mitsubishicorp.com/us/en/mca/

Mitsubishi Corporation (Americas) is a globally integrated business enterprise that develops and operates businesses across every industry. These include consumer industry, natural gas, industrial materials, automotive and mobility, mineral resources, urban development, industrial infrastructure, petroleum and chemicals, power solution, and foodindustry.Mitsubishi Corporation (Americas) leveraging their knowledge of industries and markets around the world to create new, sustainable businesses. They add value through its ability to finance and invest in the development of companies and projects, as well as through its expertise in developing the upstream and downstream activities needed for businesses to succeed. The company's current activities have expanded far beyond its traditional trading operations to include project development, production, and manufacturing operations, working in collaboration with our trusted partners around the globe.Mitsubishi Corporation (Americas) was established in 2012 and is based in New York, NY, USA.

## Contacts

5 contacts available for Mitsubishi Corporation (Americas). Shizune tracks 2 team members at Mitsubishi Corporation (Americas). Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/mitsubishi-corporation-americas?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Life Science | 1 | 50% |
| Therapeutics | 1 | 50% |
| Biotechnology | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Series B | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Hidenori Takaoka | President and CEO | 0 | https://shizune.co/investors/profile/hidenori-takaoka |
| Takahiro Tokuda | COO | 1 | https://shizune.co/investors/profile/takahiro-tokuda-6f3a |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Wheeler Bio | Wheeler Bio is a new biomanufacturing company designed to accelerate the translation of therapeutic innovation into clinical impact. Through parallel integration with pre-clinical discovery, Wheeler is democratizing access to comprehensive discovery-to-IND programs with its rapid, high-quality biomanufacturing and portable CMC platform. | $35M | Series A | Mar 20, 2025 |  |
| Heirloom | Heirloom is a provider of direct air capture technology to enhance the natural process of CO2 absorption from the atmosphere. Its technology accelerates limestone's ability to capture carbon dioxide, storing it permanently underground while operating with renewable energy. | $150M | Series B | Dec 04, 2024 |  |

2 of 2 investments shown.

## Co-investors
- [Ahren Innovation Capital](https://shizune.co/investors/profile/ahren-innovation-capital) — VC Fund, 1 deal together
- [Alloy Therapeutics](https://shizune.co/investors/profile/alloy-therapeutics) — VC Fund, 1 deal together
- [Breakthrough Energy Ventures](https://shizune.co/investors/profile/breakthrough-energy-ventures) — VC Fund, 1 deal together
- [Carbon Direct Capital](https://shizune.co/investors/profile/carbon-direct) — VC Fund, 1 deal together
- [Echo Investment Capital](https://shizune.co/investors/profile/echo-investment-capital) — VC Fund, 1 deal together
- [Future Positive](https://shizune.co/investors/profile/future-positive) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Mitsubishi Corporation (Americas) invest in?

Mitsubishi Corporation (Americas) invests primarily in Life Science, Therapeutics and Biotechnology startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Mitsubishi Corporation (Americas)?

Public channels for Mitsubishi Corporation (Americas) include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Mitsubishi Corporation (Americas)?

The team at Mitsubishi Corporation (Americas) includes Hidenori Takaoka (President and CEO) and Takahiro Tokuda (COO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co